Product NDC: | 62856-243 |
Proprietary Name: | AcipHex |
Non Proprietary Name: | rabeprazole sodium |
Active Ingredient(s): | 20 mg/1 & nbsp; rabeprazole sodium |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, DELAYED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 62856-243 |
Labeler Name: | Eisai Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020973 |
Marketing Category: | NDA |
Start Marketing Date: | 19990819 |
Package NDC: | 62856-243-30 |
Package Description: | 30 TABLET, DELAYED RELEASE in 1 BOTTLE (62856-243-30) |
NDC Code | 62856-243-30 |
Proprietary Name | AcipHex |
Package Description | 30 TABLET, DELAYED RELEASE in 1 BOTTLE (62856-243-30) |
Product NDC | 62856-243 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | rabeprazole sodium |
Dosage Form Name | TABLET, DELAYED RELEASE |
Route Name | ORAL |
Start Marketing Date | 19990819 |
Marketing Category Name | NDA |
Labeler Name | Eisai Inc. |
Substance Name | RABEPRAZOLE SODIUM |
Strength Number | 20 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] |